Literature DB >> 7821352

Investigation of the role of tachykinin NK1, NK2 receptors and CGRP receptors in neurogenic plasma protein extravasation in dura mater.

C T O'Shaughnessy1, H E Connor.   

Abstract

The aim of this study was to investigate the role of tachykinin NK1 and NK2 receptors, and calcitonin gene-related peptide (CGRP) receptors in neurogenic plasma protein extravasation, induced by electrical stimulation of the trigeminal ganglion, in dura mater of anaesthetised rats and guinea-pigs. This response was significantly (P < 0.05) blocked in both species by the selective peptide tachykinin NK1 receptor antagonist, GR82334 ([D-Pro9[spiro-gamma-lactam]Leu10,Trp11]physalaemin-(1-11)) (0.02-0.2 mg/kg i.v.) whilst the selective tachykinin NK2 receptor antagonist, (+/-)-SR 48968 ((S)-N-methyl-N-[4-(4-acetylamino-4-phenylpiperidino)-2-(3,4- dichlorophenyl) butyl] benzamide) (1 mg/kg i.v.) was without effect. The CGRP receptor antagonist, alpha-CGRP-(8-37) (0.1 mg/kg i.v.) significantly (P < 0.05) blocked this response in dura mater of guinea-pigs but not rats. These results suggest that substance P, acting via tachykinin NK1 rather than NK2 receptors, mediates neurogenic plasma protein extravasation in dura mater and that CGRP may have an involvement in this response in guinea-pigs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7821352     DOI: 10.1016/0014-2999(94)90541-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

Review 1.  Modelling headache and migraine and its pharmacological manipulation.

Authors:  S E Erdener; T Dalkara
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

2.  Tonabersat (SB-220453) a novel benzopyran with anticonvulsant properties attenuates trigeminal nerve-induced neurovascular reflexes.

Authors:  A A Parsons; S Bingham; P Raval; S Read; M Thompson; N Upton
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

3.  Trigeminal nerve ganglion stimulation-induced neurovascular reflexes in the anaesthetized cat: role of endothelin(B) receptors in carotid vasodilatation.

Authors:  P Raval; S Bingham; N Aiyar; J D Elliott; A J Hunter; E H Ohlstein; A A Parsons
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

4.  A novel CGRP-neutralizing Spiegelmer attenuates neurogenic plasma protein extravasation.

Authors:  K Hoehlig; K W Johnson; E Pryazhnikov; C Maasch; A Clemens-Smith; W G Purschke; S Vauléon; K Buchner; F Jarosch; L Khiroug; A Vater; S Klussmann
Journal:  Br J Pharmacol       Date:  2015-03-27       Impact factor: 8.739

5.  Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches.

Authors:  Zdravko Lacković; Boris Filipović; Ivica Matak; Zsuzsanna Helyes
Journal:  Br J Pharmacol       Date:  2016-01       Impact factor: 8.739

Review 6.  Animal migraine models for drug development: status and future perspectives.

Authors:  Inger Jansen-Olesen; Peer Tfelt-Hansen; Jes Olesen
Journal:  CNS Drugs       Date:  2013-12       Impact factor: 5.749

Review 7.  Neurovascular contributions to migraine: Moving beyond vasodilation.

Authors:  Blaine Jacobs; Gregory Dussor
Journal:  Neuroscience       Date:  2016-06-14       Impact factor: 3.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.